Skip to main content

The Enterprise African Research Network (EARN)

EARN was established in 2020 to support African researchers in their ongoing efforts to​ mobilize​, advocate​ and coordinate​ action and funding towards an increased role in shaping the HIV vaccine research and development (R&D) agenda.

The EARN programme is composed of:

  1. The Vaccine Academy

  2. The Mentorship Programme

  3. The Fellowship Programme

Through these activities, the Enterprise African Research Network works towards the following objectives: 

  1. Increase knowledge and skills of African researchers in HIV vaccine R&D. 

  2. Provide small research grants to early- and mid-career African scientists.

  3. Develop a global network supporting African researchers to develop their careers in HIV vaccine R&D.  

The Steering Committee comprises experts in the HIV vaccine field. It is responsible for the development of the HIV Vaccine Science Academy programme, identification of key faculty, review of applications and selection of fellows.

Meet the Steering Committee:

Linda-Gail Bekker

Linda-Gail Bekker

Desmond Tutu HIV Centre
South Africa
View
Wendy Burgers

Wendy Burgers

University of Cape Town
South Africa
View
Kundai Chinyenze

Kundai Chinyenze

International AIDS Vaccine Initiative (IAVI)
Kenya
View
Jonathan Fuchs

Jonathan Fuchs

San Francisco Department of Public Health
United States
View
Nigel Garrett

Nigel Garrett

Centre for the AIDS Programme of Research in South Africa (CAPRISA)
South Africa
View
William Kilembe

William Kilembe

Zambia Emory HIV Research Project
Zambia
View
Penny Moore

Penny Moore

National Institute for Communicable Diseases (NICD)
South Africa
View
Thumbi Ndung’u

Thumbi Ndung’u

Africa Health Research Institute (AHRI)
South Africa
View
Julien Nyombayire

Julien Nyombayire

Rwanda Zambia Health Research Group – Projet San Francisco
Rwanda
View
Sandhya Vasan

Sandhya Vasan

Henry M. Jackson Foundation (HJF)
United States
View

The HIV Vaccine Enterprise Academy

The HIV Vaccine Academy is designed to support early- to mid-career researchers from central, eastern, western and southern Africa in establishing themselves as independent researchers and team leaders in their respective host institutions, thus contributing to long-term continuity, networking and research ownership in Africa in the response to HIV.

Objectives:

  1. Train on state-of-the-art HIV vaccine research and development, notably vaccine design, trial design, laboratory and data analysis and training in the use of relevant scientific tools and skills (for example, scientific writing).

  2. Provide opportunities for the participants to engage and discuss with leaders in the HIV vaccine field in a retreat-type setting, with a view to building and facilitating collaborations in the search for an HIV vaccine.

  3. Provide opportunities for participants to establish a sustainable network across different research institutions and create momentum for African-led research.

  4. Identify mentees for a mentorship scheme to ensure long-term beneficial impact and continued educational opportunities and to provide critical guidance and further networking.

HIV Vaccine Enterprise Academy, Wits Rural Facility, Bushbuckridge, South Africa
The first-ever HIV Vaccine Enterprise Academy was held at the Wits Rural Facility, Bushbuckridge, South Africa, on 15-18 March 2023.

Download the booklet here.

Academy participant Mildred Obare was featured in the #IASONEVOICE campaign on World Creativity and Innovation Day in April 2023.

Mildred Obare #IASONEVOICEFacilitating collaborating through a data-sharing platform will lay the groundwork for more efficient and effective research that can lead to new discoveries and hopefully an effective HIV vaccine.

Mildred Obare
Physician, human rights activist & IAS member

The Mentorship Programme

The Mentorship Programme is designed for early- and mid-career investigators conducting HIV vaccine research in Africa as a critical step for these investigators to increase productivity, self-efficacy and career satisfaction.

Objectives:

  1. Inspire mentees to set goals for personal growth and learning.

  2. Connect established scientific leaders in the HIV vaccine field around the globe with junior scientists from central, eastern, western and southern Africa.

  3. Provide mentees with guidance, advice and feedback from mentors with more experience.

  4. Increase mentees’ productivity, self-efficacy and career satisfaction.

  5. Provide an opportunity for mentees to establish personal and professional relationships across different research institutions and create momentum for African-led research.

IAS mentor, Gerald Chege"The IAS Mentorship Programme is not only connecting early-career investigators with established leaders in the field of HIV research, but it is also providing means of removing historical barriers to effective collaborations and networking among the African researchers."

IAS mentor, Gerald Chege

IAS mentee, Francisca Seraphina"The IAS Mentorship Programme provides invaluable support to early-career investigators, promoting networking and knowledge exchange. Mentees benefit from mentor guidance, fostering professional growth and enhancing their research capabilities."

IAS mentee, Francisca Seraphina

Looking ahead: The Fellowship Programme

The Global HIV Vaccine Enterprise aims to support early- and mid-career investigators conducting HIV vaccine research in Africa by providing opportunities for training, networking and mentorship.

Objectives:

  1. Develop and foster state-of-the-art HIV vaccine research in central, eastern, western and southern Africa in collaboration with international research institutions.

  2. Train and retain postdoctoral researchers in the HIV vaccine research space in central, eastern, western and southern Africa.

  3. Equip fellows to establish themselves as independent researchers with the ability to establish their own research teams at host institutions in central, eastern, western and southern Africa.

  4. Establish sustainable research networks between research institutions in different environments around the globe

Selected applicants will enrol in a two-year research programme that may include time spent in an international institution with the aim of conducting a research project focusing on HIV vaccine development. During the course of the programme, they will receive technical and scientific training. Senior researchers and scientists are encouraged to support fellows in their institution of origin and partner organizations as co-mentors.

This project has not yet been implemented and depends on securing new funding. If you are a funder interested in the project, please reach out to the Project Manager, Capacity Building, Asli Heitzer, at [email protected].